Effect of the Telemedicine Enhanced Asthma Management-Uniting Providers (TEAM-UP) Program on Asthma Outcomes: A

Jill S Halterman1, Maria Fagnano1, Paul J Tremblay1

  • 1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY.

The Journal of Pediatrics
|October 25, 2025
PubMed

Insights

A school-based intervention combining telemedicine and observed therapy improved asthma control in children. This approach increased symptom-free days and reduced emergency visits for children with persistent asthma.

Area of Science:

  • Pediatric Pulmonology
  • Health Services Research
  • Digital Health

Background:

  • Asthma is a common chronic respiratory disease in children, often requiring ongoing management.
  • Moderate-to-severe persistent asthma significantly impacts children's quality of life and healthcare utilization.
  • Underserved communities face unique challenges in accessing consistent asthma care.

Purpose of the Study:

  • To evaluate a school-based intervention for children with moderate-to-severe persistent asthma.
  • To assess the impact of integrating telemedicine consultations with school-based directly observed therapy (DOT) for preventive asthma medications.
  • To optimize asthma management and reduce healthcare use in pediatric populations.

Main Methods:

  • A randomized controlled trial involving 326 children aged 4-12 years with poorly controlled asthma.
  • Intervention group: Telemedicine Enhanced Asthma Management-Uniting Providers (TEAM-UP) with daily school-based DOT and specialist telemedicine visits.
  • Control group: Enhanced usual care. Primary outcome: Mean symptom-free days per 2 weeks.

Main Results:

  • Children in the TEAM-UP group experienced significantly more symptom-free days (mean difference: 1.32 days/2 weeks).
  • The TEAM-UP intervention was associated with reduced school absenteeism (OR: 0.70) and fewer emergency department visits or hospitalizations for asthma (OR: 0.54).
  • High participation in specialist visits (84%) and DOT (74%) was observed in the intervention group.

Conclusions:

  • The TEAM-UP intervention significantly improved asthma symptom control in children.
  • This model effectively reduced healthcare utilization, including emergency visits and hospitalizations.
  • School-based telemedicine combined with DOT offers a promising strategy for asthma care in underserved communities.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722